These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 22362985)
1. Science in India. Crowd-sourcing drug discovery. Bagla P Science; 2012 Feb; 335(6071):909. PubMed ID: 22362985 [No Abstract] [Full Text] [Related]
2. Gradual filling up of TB drug pipeline: how can we play our role better? Kant L Indian J Tuberc; 2009 Jan; 56(1):1-4. PubMed ID: 19402265 [No Abstract] [Full Text] [Related]
3. Welcome to 'Tuberculosis drug discovery and development'. D'Oca G Future Med Chem; 2010 Aug; 2(8):1241-2. PubMed ID: 21426014 [No Abstract] [Full Text] [Related]
4. Emerging drugs for active tuberculosis. Ginsberg AM Semin Respir Crit Care Med; 2008 Oct; 29(5):552-9. PubMed ID: 18810688 [TBL] [Abstract][Full Text] [Related]
5. New tuberculosis drugs on the horizon. Cole ST; Riccardi G Curr Opin Microbiol; 2011 Oct; 14(5):570-6. PubMed ID: 21821466 [TBL] [Abstract][Full Text] [Related]
6. High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Almeida D; Rodrigues C; Ashavaid TF; Lalvani A; Udwadia ZF; Mehta A Clin Infect Dis; 2005 Mar; 40(6):881-6. PubMed ID: 15736024 [TBL] [Abstract][Full Text] [Related]
7. Structural genomics approach to drug discovery for Mycobacterium tuberculosis. Ioerger TR; Sacchettini JC Curr Opin Microbiol; 2009 Jun; 12(3):318-25. PubMed ID: 19481971 [TBL] [Abstract][Full Text] [Related]
8. Challenges and opportunities in tuberculosis drug discovery: an industry perspective. Shirude PS; Ramachandran S; Hosagrahara V Future Med Chem; 2013 Apr; 5(5):499-501. PubMed ID: 23573967 [No Abstract] [Full Text] [Related]
11. Tuberculosis control: detect and treat infection in children. John TJ Indian Pediatr; 2008 Apr; 45(4):261-4. PubMed ID: 18451442 [No Abstract] [Full Text] [Related]
12. [Mycobacterium tuberculosis after five 5-year periods of specific therapy. Biological aspects]. Daddi G Ann Ist Carlo Forlanini; 1969; 29(4):283-5. PubMed ID: 5004327 [No Abstract] [Full Text] [Related]
13. Determination of drug susceptibility patterns and genotypes of Mycobacterium tuberculosis isolates from Kanpur district, North India. Purwar S; Chaudhari S; Katoch VM; Sampath A; Sharma P; Upadhyay P; Chauhan DS Infect Genet Evol; 2011 Mar; 11(2):469-75. PubMed ID: 21237291 [TBL] [Abstract][Full Text] [Related]
15. More on tuberculosis. Chaudhuri A Lancet; 2008 Feb; 371(9613):647. PubMed ID: 18295017 [No Abstract] [Full Text] [Related]
16. New anti-tuberculosis drugs in clinical trials with novel mechanisms of action. Rivers EC; Mancera RL Drug Discov Today; 2008 Dec; 13(23-24):1090-8. PubMed ID: 18840542 [TBL] [Abstract][Full Text] [Related]
17. Tuberculosis drug resistance: summary report for 2003. Can Commun Dis Rep; 2004 May; 30(10):93-5. PubMed ID: 15174496 [No Abstract] [Full Text] [Related]
18. High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery. Christophe T; Ewann F; Jeon HK; Cechetto J; Brodin P Future Med Chem; 2010 Aug; 2(8):1283-93. PubMed ID: 21426019 [TBL] [Abstract][Full Text] [Related]
19. [Resistance to antitubercular drugs in patients with tuberculosis registered in the antituberculosis clinics in Poland 1966-1980]. Szczuka I Pneumonol Pol; 1982 Oct; 50(10):497-501. PubMed ID: 6820494 [No Abstract] [Full Text] [Related]
20. Further acquisition of drug-resistance in multidrug-resistant tuberculosis during chemotherapy. Toyota E; Sekiguchi J; Shimizu H; Fujino T; Otsuka Y; Yoshikura H; Kuratsuji T; Kirikae T; Kudo K Jpn J Infect Dis; 2004 Dec; 57(6):292-4. PubMed ID: 15623961 [No Abstract] [Full Text] [Related] [Next] [New Search]